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                                    1. INTRODUCTION                                           
 
                                   Among  all  the  neurological  diseases of adult  life, Cerebro  
 
vascular   accidents   clearly    ranks   first  in   frequency  of  importance. At  least   
 
fifty    percent   of  neurological   diseases   in general  hospital  are due to   stroke.   
 
Cerebro  vascular  accident  includes  ischemic stroke,  hemorrhagic  stroke,   and  
 
cerebro vascular anomalies  such  as   intracranial   aneurysm,  AV   malformation    
 
and  cortical venous  thrombosis. Stroke, after heart   disease  and  cancer,  is  the  
 
third most common cause of death1 .With the introduction  of  effective  treatment   
 
for  hypertension,   there  has   been   a  marked    reduction  in  the  frequency   of  
 
stroke. 
   
                         Diabetes mellitus by virtue of  its  association  with micro vascular  
 
and macrovascular2  disease is an  important risk  factor  in  the  genesis  of  stroke.  
 
Most of  the diabetic  patients  with  stroke  have  raised  glycosylated  hemoglobin  
 
indicating  that   most  of  them  have  uncontrolled  diabetes. Diabetics and   stress  
 
Hyperglycemics   have   severe   strokes  resulting  in   poor   outcome.   Stroke   is  
 
twice3 more common in  diabetics  than in non diabetics. Hypertension is common  
 
in  diabetes  and  accelerates  atherosclerosis  which   promotes  intracranial   small  
 
vessel   disease  and   heart   disease   leading   to  lacunar  and  embolic  infarction                
 
respectively. There  are several  risk factors  that determine the outcome of  stroke.  
 
Hyperglycemia,   fever ,  neuroprotective   agents   are   those   which  are   widely  
 
studied. 
                                                                          1                                                                     
 
                              2. AIM  OF  THE  STUDY                                        
 
 
 
 
 
To  measure  the  blood  glucose  level  within   twenty   four  hours  of   the  onset 
 
of   stoke  in  both  diabetics and  in   non diabetics  and  to   evaluate  the  severity 
 
and  prognosis in  both diabetics and  non diabetics  in  relation  to hyperglycemia. 
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3. REVIEW  OF  LITERATURE 
 
 
                                                                                                                                                       
 DEFINITION :                         
 
 
                      Stroke (cerebro vascular accident) is a rapidly developing episode of 
focal and at times global  loss of    cerebral function    with  symptoms lasting 
more than 24hours or leading to death with no apparent  cause  other than that of 
vascular origin. 4 
. 
                      Transient ischemic attack (TIA) is an acute loss of   focal cerebral 
or monocular function with symptoms   lasting less than 24hours. 
                       
                      Reversible ischemic neurological deficit (RIND) refers to 
neurological deficit that disappears within 7 days of onset. 
             
EPIDEMIOLOGY         
 
RISK FACTORS 5  
 
NON-MODIFIABLE RISK FACTORS   
 
Age : Increasing age is most powerful risk factor  for cerebral 
infarction , intracerebral hemorrhage and subarachnoid hemorrhage as well as TIA  
                         Sex : men are more at risk for ischemic stroke than woman up to  
75 years of age. 
                                                                     3 
                        Race : the risk is more in Blacks than Whites                                                                 
                       Family history : there is an increased incidence of stroke  in 
individuals  who   have  a  first degree  relative  affected  with stroke  or who  have 
paternal or maternal history of death or disability due to  stroke 
MODIFIABLE RISK FACTORS  5                     
                         Hypertension :  It is an important predisposing factor not only for  
cerebral  hemorrhage but also for infarction. Both systolic and diastolic pressures 
contribute to the risk though there is no critical level above which it operates. The 
reduction of BP by 10-12mmHg systolic and 5-6mmHg diastolic was found to be 
associated with 38% reduction in stroke incidence.      
               Diabetes mellitus : It is an independent risk factor for stroke. It 
increases   the  susceptibility  to  coronary , femoral , and cerebral  atherosclerosis. 
The relative  risk  increases  two  to  fourfold  in  diabetics  patients  with  diabetic 
complications like retinopathy and autonomic neuropathy have a higher incidence 
of ischemic stroke  
                        Hyperglycemia  And  Stroke : 
 
                        Elevated blood glucose is common in the early phase of stroke. The  
 
prevalence of hyperglycemia, defined as blood glucose level  more than 6.1mmol/l  
 
has been observed in two third of all ischemic stroke subtypes  on  admission  and  
 
in at  least  fifty  percent  in  each  subtype  including  lacunar  stroke6.  Extensive  
 
experimental  evidence in  stroke  models  support  that  association between blood  
 
             4 
glucose  and  functional  outcome has been found in increasing  number of clinical  
 
studies. Although  no  intervention  stroke  studies  have  addressed  the reversal of  
 
hyperglycemia, active lowering of elevated blood glucose by rapidly acting insulin  
 
is recommended  in  most  published  guidelines ,  even  in  non   diabetic  patients  
 
(European Stroke  Initiative,  EUSI,  guidelines  >  10  mmol/l  ; American  Stroke    
 
Association, ASA, guidelines > 300 mg/dl) 7. 
 
 
Causes  of  Acute Hyperglycemia :  
 
                          Although up to  one  third  of  acutely  stroke  patients  have either  
 
diagnosed  or  newly  diabetic, probably  a major proportion of patients have stress  
 
hyperglycemia, mediated partly by the release of cortisol and nor epinephrine. It is  
 
also  a  manifestation   of  relative  insulin  deficiency,  which   is   associated  with  
 
increased  lipolysis  even  in  non diabetic patients; stress  hyperglycemia may be a  
 
marker   of   glucose  regulation    in   individuals   with   insulin    resistance    and  
 
developing diabetes.  
                                                                                                              
                          Hypercholesterolemia :   It is a  secondary  risk  factor  indirectly  
 affecting the risk of stroke. Reducing high cholesterol levels decreases the 
incidence   of coronary artery disease which is the main cause of mortality in 
patients with cerebro vascular disease.        
                 Non valvular atrial fibrillation : It  is common in the age 
group of  65 –  85years and attributes  to a  five fold increase  in  the  incidence  of      
5 
embolic stroke especially in   those patients who have recent CCF , arterial 
hypertension and   prior   thrombo embolism.      
        Cigarette smoking : It increases the risk of infarction in men 
and women by predisposing to carotid atherosclerosis. Smokers experience a 
reduction in  stroke  risk only after 5 years following cessation of smoking.  
       Alcohol : Light to moderate intake reduces the risk by increasing 
the  HDL concentration, whereas heavy drinking increases the risk. More than one  
drink per day for women and more than two per day  for men increases the BP, 
obesity and triglycerides level thereby increasing the risk.                   
                 TIA :  Three times greater risk for subsequent stroke or death due   
to vascular causes ,especially those with hemispherical TIA. Patients with a  
previous history of stroke are at risk for a subsequent stroke. The risk of   stroke 
recurrence is increased by the presence of dementia. 
    Carotid artery stenosis : Asymptomatic  Carotid artery stenosis   
less than 75% carries a risk of 1.3% annually whereas risk increases to 10.5%  per 
year if the stenosis is greater than 75%. Ulcerated .echoluscent and  heterogeneous 
plaques with a soft-core are at higher risk for embolism.    
  Blood factors : Elevated haematocrit , hemoglobin and viscosity  of 
the blood is associated with increased risk of  ischemic stroke. Higher mean levels 
of plasma fibrinogen, factor VIII , von willebrand’s factor, anti-thrombin III and 
lower  mean levels  of   protein C   is    associated   with    increased  risk.   The  
        6 
Antiphospholipid antibodies is associated with increased  risk of  ischemic stroke. 
Serum folate concentration less than or equal to 9.2   nmol/L alone may be risk  
factor  for ischemic stroke. 
             Hormones : High dose estrogen oral contraceptives increases the 
risk   of stroke in young women , while postmenopausal estrogen supplementation 
reduces the risk. The risk of cerebral infarction is increased in the first 6 weeks   
following delivery.          
     Others : Abdominal or truncal obesity, physical inactivity, 
habitual   snoring are associated with increased risk of ischemic stroke. 
PATHOPHYSIOLOGY          
               Stroke is 90% ischemic and 10 % hemorrhagic8 . Abrupt disruption 
of  focal cerebral blood flow causes acute ischemic stroke .The causes of 
decreased   cerebral blood flow includes abrupt occlusion of small penetrating 
arteries  arterioles, single or multiple arterial stenosis, arteritis, arterial dissection, 
venous  occlusion, and profound anemia.     
                 When cerebral blood flow falls below a critical value of 20ml 
/100g/min there is a loss of neuronal electrical function which is a reversible. 
When cerebral blood flow falls below a critical value of 10ml / 100g/min then   
aerobic  mitochondrial metabolism fails and anaerobic metabolism leads to    lactic   
acidosis.            
   As  a  sequel to  this   sodium  and  water   enters  the  cell  and  potassium  
7 
leaks   out of  the cell due to failure of energy dependent intracellular 
homoeostasis  leading to  irreversible cell death.      
 Based on these facts the concept of ischemic penumbra was 
formulated. It is   an area of brain that has reached the reversible stage of electrical 
failure but has not yet passed into the irreversible stage. Thrombolytic  agents are 
used in this time window to salvage the ischemic penumbra  zone. 
 
HOW ELEVATED GLUCOSE INJURES THE ISCHEMIC BRAIN 
 
                       By provoking anaerobic metabolism, lactic acidosis and free radical  
 
production, hyperglycemia may exert direct membrane lipid per oxidation and cell  
 
lysis in metabolically challenged tissues. Moderately and severely increased blood  
 
glucose has been found to further the metabolic state  and  mitochondrial  function  
 
in the area and ischemic penumbra9. Insulin  resistance  is a  known risk factor  for  
 
the onset of stroke acting through a number of  intermediate  vascular  disease  risk  
 
factors  ( i.e.  thrombophilia,  endothelial  dysfunction  and  inflammation ) 10.  The  
 
evolution of acute infarction may be explained by the very same  vascular  factors,  
 
explaining why ischemic time seems to fly faster in patients with diabetes or grave  
 
hyperglycemia. Relative  insulin  deficiency  liberates  circulating  free fatty acids,  
 
which     together    with    hyperglycemia,    diminishes    vascular    reactivity11,12.  
 
Furthermore, lowering  glucose  with insulin  has been reported to reduce ischemic  
 
brain damage in an animal model13. 
                     
                        The evolution of an infarction is accompanied by glutamate release  
       8 
mediating  repeated  waves  of  spreading  depression  (SD) ,  another   mechanism  
 
believed  to  propagate the necrosis of penumbral tissues. Although hyperglycemia  
 
alone did not trigger  early response genes in cortical tissues of rats, in conjunction  
 
with induced SD, the expression of c-fos and cox-2 were substantially increased14.  
 
This  suggested   that   increased   glucose    may   trigger   untoward   intracellular  
 
biochemical  cascades  also  by  altering  early  gene  expression  in   metabolically  
                                                                                                                                 
challenged   neurons. 
  
                     The   blood  brain  barrier   is    well   known   to   be   vulnerable   to  
 
hyperglycemia, presumably through the liberation of lactic acid and  free  radicals.  
 
The recent experimental study by Song et al in a rat model of collagenase induced  
 
intra cerebral hemorrhage add that hyperglycemia aggravates edema  formation  in  
 
zone surrounding the  hemorrhage15.  The  study  also  documented  increased  cell  
 
death measured  by  TUNNEL  staining.  It  is  conceivable  that  hemorrhages  are  
 
surrounded  by  a  one  of  similarly challenged tissues as infarctions are where the  
 
availability  of  glucose  influences  the  metabolic   state.  
 
 
COMMON  CAUSES  OF  ISCHEMIC STROKE : 
 
  
1.Thrombosis 
 
       Lacunar stroke (small vessel) 
 
        Large vessel thrombosis 
 
         Dehydration 
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 2.Embolic occlusion 
 
      A. Artery-to-artery 
 
          Carotid bifurcation 
 
          Aortic arch, Arterial dissection 
 
      B. Cardio embolic 
 
          Atrial fibrillation 
 
           Mural thrombus 
 
           Myocardial infarction 
 
           Dilated cardiomyopathy 
 
          Valvular lesions 
 
                      Mitral stenosis 
 
                      Mechanical valve 
 
                      Bacterial endocarditis 
 
            Paradoxical embolus 
 
                       Atrial septal defect 
 
                       Patent foramen ovale 
 
            Atrial septal aneurysm 
  
            Spontaneous echo contrast 
 
UNCOMMON  CAUSES : 
 
1. Hypercoagulable disorders 
 
                 Protein C deficiency 
         10 
                 Protein S deficiency 
 
                 Anti thrombin III deficiency 
 
          Antiphospholipid syndrome 
 
                  Factor V Leiden mutation 
 
                  Prothrombin G20210 mutation 
 
                  Systemic malignancy 
 
                  Sickle cell anemia 
 
                  Beta Thalassemia 
 
                  Polycythemia Vera 
 
                  Systemic lupus erythematosus 
 
                   Homocysteinemia 
 
                   Thrombotic thrombocytopenic purpura      
                       
                   Disseminated intravascular coagulation 
 
                   Dysproteinemias 
 
                   Nephrotic syndrome 
 
                    Inflammatory bowel disease 
 
                    Oral contraceptives 
 
2. Venous sinus thrombosis 
 
3. Fibro muscular dysplasia 
 
4. Vasculitis                     Systemic vasculitis 
                                      
                                      (PAN, Wegner's, Takayasu's, giant cell  arteritis )  
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                                    Primary CNS vasculitis 
 
                Meningitis (syphilis, tuberculosis, fungal, bacterial, zoster) 
     
  5. Cardiogenic 
 
             Mitral valve  calcification 
 
                       Atrial myxoma  
            
                        Intra  cardiac tumor 
                         
                        Marantic endocarditis 
                                                                                                     
                        Libman-Sacks endocarditis 
 
  6. Subarachnoid hemorrhage vasospasm 
                                                                                                         
  7. Drugs: cocaine, amphetamine 
 
8. Moyamoya disease 
 
9. Eclampsia.     
                 
 
CLINICAL SYNDROMES 5 
 
TRANSIENT ISCHAEMIC ATTACKS    
 
                   TIAs are abrupt in onset , brief in duration  and recovery is possible  
  
   in  24 hours . Recurrent TIAs can occur. Recognition and treatment is  important  
 
   as a complete stroke can be prevented. 
 
Carotid  TIAs           
           These are characterized by monocular blindness with recovery within     
Few minutes, visual field disturbance  in  the  form  of  transient  hemianopia   and    
            12 
speech disturbance due to dominant hemispherical dysfunction.  Hemi paresis and 
hemi sensory loss can occur both in vertebro basilar   TIAs as well as carotid 
TIAs.  
Vertebro Basilar TIAs       
                    These are characterized by prominent visual symptoms like 
Diplopia,  homonymous hemianopia and cortical blindness, transient vertigo 
dizziness, unsteadiness due to cerebellar dysfunction and transient lower cranial 
nerve symptoms like dysarthria, perioral numbness, nasal regurgitation.  
           Drop attacks occur without any warning .It is  thought  to  be  
due  to ischemia of relays in reticular systems which normally function  as  part  of  
reflex antigravity mechanism. 
        
Subclavian steal 
 
                   This syndrome occurs when there is occlusion of the Subclavian 
artery proximal to origin of vertebral artery which results in retrograde flow of 
blood down the vertebral artery during exercising the arm thereby leading on to 
symptoms of hindbrain ischemia.       
Mini Strokes          
                     Mini strokes are characterized by episodic ischemic symptoms 
which  recover within  24 hours but there are small infarcts or hemorrhage in CT 
and are  as significant as the TIAs 
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 Stroke in  evolution 
 
     Stroke in  evolution refers to the slow progression of neurological 
deficit  over several hours.        
 Major strokes 
     
                  Major stroke are of sudden onset with loss of consciousness at the 
onset or   soon after. It is very difficult to distinguish clinically between infarction 
or    hemorrhage. Headache and vomiting if present, usually denotes hemorrhage  
especially if it is associated with rapid loss of consciousness. Athero –thrombo 
embolism is   suggested by the presence of bruit over the carotid arteries.   
  Unusual  types of stroke 
 
                               Multi-infarct dementia, watershed infarction. 
           
                                                                                                                                 
Classification of stroke on the basis of oxford shire community stroke  
 
Sub classification 16 
 
       Total anterior  circulation syndrome (TACS) 
           
    Implies a large cortical stroke in middle cerebral or middle and 
anterior   cerebral artery territories. it is characterized by a combination of 
 new higher cerebral dysfunction 
 
 Homonymous visual field defect 
 
 an ipsilateral motor and / or sensory deficit involving at least  
     14 
     two out of  three areas of the face , arm or leg     
 Partial  anterior  circulation syndrome 
 
             Implies  a cortical stroke in middle or anterior cerebral arterial  
territory . This includes  patients with two out of three   components  of   the      
Total    anterior  circulation syndromes or new higher cerebral dysfunction alone 
or    motor / sensory deficit more restricted than those classified as a TACS .  
   Lacunar syndrome 
 
           Implies a sub cortical stroke due to a small vessel disease 
 
•  Pure motor stroke 
 
•  Pure sensory stroke 
 
•  sensory motor stroke 
                                                                                                 
•  ataxic hemi paresis   
 
Evidence of higher cortical dysfunction or disturbance of consciousness   excludes  
Lacunar syndrome.            
posterior circulation syndrome 
 1. Ipsilateral cranial nerve palsy with contra lateral motor and sensory deficit,           
2. Bilateral motor and or sensory deficit  
3. Disorder of conjugate eye  movement  
4. Cerebellar dysfunction without ipsilateral long tract involvement  
5. Isolated homonymous visual field defects 
 
15 
 
 
 
 
 
ANTERIOR CEREBRAL CIRCULATION SYNDROME 
 
 
 
 
 
no Signs and symptoms Structures involved 
1. Paralysis of opposite foot and leg Motor leg area 
2. Lesser degree of paresis of opposite arm Involvement of cortical / 
corona radiata of arm 
fibers 
3. Cortical sensory loss over toes, foot and leg Sensory area for foot and 
leg 
4. Urinary incontinence Sensory motor area in 
Para central lobule 
5. Contralateral grasp reflex,suckling reflex, 
gegenhalten 
Medial surface of the 
posterior frontal lobe 
6. Abulia,slowness,delay,intermittentinterruption, 
lack of spontaneous whispering, reflex 
distraction to sights and sounds 
Cingulate gyrus, medial 
inferior portion of 
frontal, parietal and 
temporal lobes 
7. Impairment of gait and stance (gait apraxia) Frontal cortex near leg 
motor area 
8. Dyspraxia of left limbs, Tactile aphasia in left 
limbs 
Corpus callosum 
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   MIDDLE CEREBRAL CIRCULATION SYNDROME 
 
 
no Signs and symptoms Structures involved 
1 Paralysis of the contra lateral face, 
arm, and leg; sensory impairment 
over the same area (pinprick, cotton 
touch, vibration, position, two-point 
discrimination, stereognosis, tactile 
localization) 
Somatic motor area for face and 
arm and the fibers descending 
from the leg area to enter the 
corona radiata and 
corresponding somatic sensory 
system 
 
2 Motor aphasia Motor speech area of the 
dominant hemisphere 
3 Central aphasia, word deafness, 
anomia, jargon speech, sensory 
agraphia, acalculia, alexia, finger 
agnosia, right-left confusion (the last 
four comprise the Gerstmann 
syndrome 
Central, suprasylvian speech 
area and parieto occipital cortex 
of the dominant hemisphere 
 
4 Conduction aphasia Central speech area (parietal 
operculum) 
5 Apractognosia of the minor 
hemisphere (amorphosynthesis), 
anosognosia, hemiasomatognosia, 
unilateral neglect, agnosia for the left 
half of external space, dressing 
"apraxia," constructional "apraxia," 
distortion of visual coordinates, 
inaccurate localization in the half 
field, impaired ability to judge 
distance, upside-down reading, visual 
illusions (e.g., it may appear that 
another person walks through a table) 
Non dominant parietal lobe 
(area corresponding to speech 
area in dominant hemisphere); 
loss of topographic memory is 
usually due to a non dominant 
lesion, occasionally to a 
dominant one) 
6 Homonymous hemianopia (often 
homonymous inferior 
quadrantanopia) 
Optic radiation deep to second 
temporal convolution 
 
7 Paralysis of conjugate gaze to the 
opposite side 
Frontal contraversive field or 
projecting fibers 
 
17 
       
   POSTERIOR CEREBRAL CIRCULATION SYNDROME 
 
   Peripheral territory 
 
no Signs and symptoms Structures involved 
1 Homonymous hemianopia (often upper 
quadrantanopia) 
Calcarine cortex or optic 
radiation 
2  Bilateral homonymous hemianopia, 
cortical blindness, awareness or denial 
of blindness; tactile naming, 
achromatopia (color blindness), failure 
to see to-and-fro movements, inability to 
perceive objects not centrally located, 
apraxia of ocular movements, inability 
to count or enumerate objects, tendency 
to run into things that the patient sees 
and tries to avoid 
 Bilateral occipital lobe with 
possibly the parietal lobe 
involved 
4 Verbal dyslexia without agraphia, color 
anomia 
 Dominant calcarine lesion 
and posterior part of corpus 
callosum.  
5  Memory defect Hippocampal lesion 
bilaterally or on the 
dominant side only 
6 Topographic disorientation and 
prosopagnosia 
Non dominant, calcarine, 
and lingual gyrus. 
7  Simultagnosia, hemi visual neglect  Dominant visual cortex, 
contra lateral hemisphere 
8  Unformed visual hallucinations, 
peduncular hallucinosis, metamorphosis, 
teleopsia, illusory visual spread, 
palinopsia, distortion of outlines, central 
photophobia 
Calcarine cortex. 
9 Complex hallucinations Non dominant hemisphere. 
                                                             
18 
                                                                                                 
POSTERIOR CEREBRAL CIRCULATION SYNDROME 
 
Central territory          
  
no Signs and symptoms Structures involved 
1 Thalamic syndrome: sensory loss (all 
modalities), spontaneous pain and 
dysesthesias, choreoathetosis, intention 
tremor, spasms of hand, mild hemi paresis 
Postero ventral nucleus of 
thalamus; involvement of 
the adjacent sub thalamus 
body or its afferent tracts 
2 Thalamo perforate syndrome: crossed 
cerebellar ataxia with ipsilateral third 
nerve palsy (Claude's syndrome) 
 Dentatothalamic tract and 
issuing third nerve 
3 Weber's syndrome: third nerve palsy and 
contra lateral hemiplegia 
Third nerve and cerebral 
peduncle 
4 Contra lateral hemiplegia Cerebral peduncle 
5  Paralysis or paresis of vertical eye 
movement, skew deviation, sluggish 
pupillary responses to light, slight miosis 
and ptosis (retraction nystagmus and 
"tucking" of the eyelids may be 
associated) 
Supranuclear fibers to third 
nerve, interstitial nucleus of 
Cajal, nucleus of 
Darkschewitsch, and 
posterior commissure 
6  Contra lateral rhythmic, ataxic action 
tremor; rhythmic postural or "holding" 
tremor (rubral tremor) 
 Dentatothalamic tract 
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DIAGNOSTIC EVALUATION OF ISCHAEMIC STROKE 17 
 
     The diagnostic evaluation should include parallel assessment of the following. 
 
           1.  Imaging of the infarct 
 
           2.  Vascular studies 
 
           3.  Cardiac evaluation 
 
           4.  Hematological and other blood testing 
 
 Imaging           
         CT scan  brain  is  done  to  differentiate hemorrhage  from  infarction.                            
Investigations  must be ordered based on the possible etiology. Cerebral 
arteriography is needed if intra arterial thrombolysis is contemplated. Angiogram 
is done if vascular stenosis is suspected and if it is negative or if  posterior 
circulation  is suspected then ,Tran cranial Doppler is done.     
CT versus MRI 
1. Only  a  minority  infarction  demonstrated  within  24 hours  on  CT. MRI  
 
      documents infarct as early 6 hours 
 
2. Anatomic  extent   and  vascular   distribution   are   better   delineated   in  
 
      MRI. Small infarctions are easily seen and white matter better visualized. 
 
3. Posterior fossa infarctions are better visualized in MRI. 
 
 
 CT scan changes in cerebral   infarction 18 
 
           Hyper acute infarct < 12 hours 
 
•  normal (50 – 60%) 
                                               20 
• Hyper dense artery(25 – 50%) 
 
• Obscuration of Lentiform nuclei 
 
            Acute infarct 12 to 24hours 
 
• Low density basal ganglia 
 
• Loss of grey white interfaces 
 
• Sulcal effacement 
 
                                                                      
            1 to 3days 
 
• Increasing mass effect 
 
•Wedge shaped low density area that involves both grey and   
 
                                                                               White matter 
 
•Hemorrhagic transformation may occur(basal ganglia and cortex are  
 
common sites) 
 
            4 to  7days 
 
• Gyral enhancement 
 
• mass effect, edema persist 
 
            1 to 8 weeks 
 
• Contrast enhancement persists 
 
• mass effect resolves 
 
           months to years  
 
• encephalomalacic changes 
 
                                               21 
 
• volume loss 
 
• calcification is rare 
 
CLINICAL CORRELATION OF HYPERGLYCEMIA AND INFARCT  
 
PROGRESSION 
 
                        Although  experimental  studies  have clarified several mechanisms  
 
by  which  hyperglycemia  influences  the  destiny  of ischemic brain issue, studies  
 
bridging the gap between clinical stroke and experimental models have been scare.  
 
Recent  advances  in  Magnetic  Resonance  Imaging   techniques  have   permitted  
 
Correlation of  loss  of  penumbral  tissue  with elevated blood glucose, which was  
 
linked to  increased  brain  lactate  production19 . Using   a   subcutaneous   glucose  
 
sensor for  continuous  monitoring  up to  seventy  two hours, the sane group could  
 
reproduce the  findings  that  the infarcts expanded more in hyperglycemic patients  
 
and  that  hyperglycemia  was  independently   associated  with  the infarct volume  
 
change20. This suggests that increased glucose not only reflects the  initial  volume  
 
of  infracted  tissue  in  the  acute  stage but is one of the true determinants of early  
                                                                                                                                 
infarct progression in men. 
 
Neurological  Pearls In Prognosis 
         
     
 factors predicting poor outcome21 
  
1. age : more than 75 years 
 
2. males : due to lack estrogen protective effect 
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3. risk factors : atrial fibrillation , DM , previous stroke 
 
4. clinical findings   
 
•  decreased consciousness at the onset 
 
• Presence of gaze deviation 
 
• Headache , nausea ,vomiting in first 24 hours 
 
• Elevated systolic BP >180 mm Hg on first day 
 
• Hyperthermia on admission 
 
• NIHSS score of 16 or more 
 
• Large vessel disease 
 
 5. Laboratory findings 
      
• High glutamine in plasma > 200 micromol / L 
 
• CRP concentration > 10.2 mg / l within 72 hours 
 
• Hyperglycemia > 7mmol / l 
 
• Platelet count < 150000 due to increased bleeding 
 
6. Neuro imaging studies 
 
•  Hyper density in a major intra cranial artery 
 
• Early CT changes within 6 hours of onset 
 
• >33 % of MCA territory involvement / multiple territory involvement           
   with mass effect 
• Hemorrhagic transformation on follow up CT / on intra cranial  
                                         
                     Doppler persisting MCA occlusion for hours 
                                               23 
• No flow on SPECT perfusion patterns 
 
• Carotid artery occlusion on conventional angiogram 
 
• MCA , basilar artery occlusion on angiogram 
 
• MRI – abnormal PWI in diffusion and perfusion weighted imaging 
 
• MRA – absence of MCA is associated with poor prognosis 
 
 
PROGNOSIS AND HYPERGLYCEMIA 
 
                        Already ample literature has  demonstrated  that  hyperglycemia  on  
 
admission is associated with worsened  clinical outcome as reviewed in a systemic  
 
overview of thirty three studies22. Glycemic  control  may  be indicated also in non  
 
diabetic patients, in which stress hyperglycemia  was  associated  with  a three fold  
 
risk  of  fatal  thirty  day  outcome  and 1.4 fold risk in of poor functional outcome.  
 
Good  glycemic  control  seems  warranted  also  in hemorrhagic stroke15, although  
 
More  clinical  information  is  needed  in this area. At least two clinical trials have  
 
Recently  been  initiated  to  examine  the efficacy of early insulin therapy in acute  
 
stroke20,23. Still there  is  no  evidence  to  prove that the reversal of hyperglycemia  
 
improves  the  prognosis,  as  it  has  been  demonstrated to do in acute myocardial  
 
infarction24and in critically ill post surgical patients25.   
 
                                                                      
TREATMENT  
 
The first goal is to prevent or reverse brain injury 
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                        The second goal is to obtain an accurate understanding of the 
stroke mechanism so one can halt progression of brain injury or begin to prevent  
a second stroke 
Treatments designed  to  reverse  or  lessen  the  amount  of  tissue  infarction   fall   
  
  Within   five categories: 
 
(1) Medical support 
 
(2)  Thrombolysis 
 
(3)  Anticoagulation 
 
(4) Antiplatelet agents 
  
(5) Neuroprotection 
 
 
(1)Medical Support        
    1.When cerebral infarction occurs, the immediate goal is to 
optimize cerebral perfusion in the surrounding ischemic area   
    2 .Preventing the common complications of bedridden patients like 
infections (pneumonia, urinary tract, and skin), deep venous thrombosis with 
pulmonary embolism.                                                                                                                     
                        3.Elevated   BP should  not  be  lowered  unless  there  is malignant   
 
hypertension  or  concomitant  myocardial ischemia. If  the  blood pressure is low,  
                                                                 
raising   it   is  advisable,  using   intravenous   fluids   or    vasopressor   drugs   to  
 
enhance perfusion within the ischemic penumbra. 
             
                      4. Treatment  of cerebral edema if necessary  
                                                                  25 
 
(2)Thrombolysis          
            
                     The use of thrombolytic agents in acute cerebral infarction has been  
studied extensively. Angiography performed within a few hours of infarction 
frequently  demonstrates arterial occlusions corresponding to patients presenting 
signs and   symptoms. It is this association of arterial occlusion with acute 
neurological   symptoms that prompted the study of thrombolytic agents in stroke 
patients. 
Agent   used  for  this  purpose  is   intravenous   recombinant  tissue 
 
 plasminogen activator (rtPA) 
 
Indication 26 
 
          Clinical  diagnosis  of  ischemic  stroke  with  clear  symptom   
 
onset within 3 hours 
 
           CT scan showing no hemorrhage or significant edema 
 
           Age more than 18 years, Consent by patient or surrogate 
 
Contraindication 26 
 
            Sustained BP > 185/110 
 
            Platelets <  100,000; HCT<  25%; glucose < 50 or > 400 
 
            Use of heparin within 48 h and prolonged PTT, or elevated INR 
                                                             
            Rapidly improving symptoms 
 
            Prior stroke or head injury within 3 months; prior intracranial hemorrhage 
                                                                                               
            Major surgery in preceding 14 days 
                                                                 26           
            Minor stroke symptoms 
 
            Gastrointestinal bleeding in preceding 21 days    
             
            Recent myocardial infarction, Coma or stupor 
 
 Administration of rtPA 27 
              
             Intravenous access with two peripheral IV lines (avoid arterial or central   
 
placement) 
 
             Review eligibility for rtPA. 
 
               Administer 0.9 mg/kg intravenously (maximum 90 mg) IV as 10% of 
total    dose  by bolus, followed by remainder of total dose over 1 h. 
             Continuous blood pressure  monitoring. 
 
             No other antithrombotic treatment for 24 h. 
 
             For decline in neurological status  or  uncontrolled  blood  pressure,  stop  
 
 infusion,  give cryoprecipitate, and reimage brain emergently 
 
               Avoid urethral catheterization for > 2 h. 
                                                                                                                                 
(3)Anticoagulation         
      The role of anticoagulation in atherothrombotic cerebral ischemia is   
uncertain.   Heparinization is  generally  accomplished  by  beginning  an  infusion   
without bolus and is monitored to maintain the activated PTT at approximately    
twice normal.         
      This regimen is maintained for 2 to 5 days. During this time the patient 
is   monitored   for   hemorrhagic   complications,   the   evaluation   is   completed       
27 
decision is made regarding the need for carotid endarterectomy, long-term 
anticoagulation, or an antiplatelet therapy.      
     If long-term anticoagulation is chosen,  warfarin   is   administered  
and   heparin discontinued when the international normalized ratio (INR) is in  the  
 range  of 2 to 3. 
(4)Antiplatelet Agents         
    Aspirin is the only antiplatelet agent that has been prospectively   
studied for the treatment of acute ischemic stroke.  The use of aspirin within 48 h 
of stroke onset reduced both stroke recurrence risk and mortality minimally        
(5)Neuroprotection         
              Neuroprotection  is   the   concept   of   providing  a   treatment  
that prolongs  the brain's tolerance to ischemia long enough to allow other 
measures to be employed to mitigate ischemia.                                                                
                         Hyperthermia , Hyperglycemia are the agents which increases the 
size of the infarct, hence hypothermia and normalizing blood sugar are powerful 
neuroprotective agents. 
HYPERGLYCEMIA  AND  THROMBOLYTIC  THERAPHY   OF  ACUTE  
 
ISCHEMIC STROKE 
 
                         In several thrombolysis trials, hyperglycemia has been  associated  
 
With  hemorrhagic  events 28 and  was  reconfirmed in recently29 as well as in a re- 
 
Analysis  of  the  NINDS rt-PA trial30. In the  latter  study, as increasing admission  
 
28 
glucose level  was  independently  associated with decreased odds for neurological  
 
improvement (odds  ratio, OR = 0.76 per 100 mg/dl increase in admission glucose)  
 
and the  odds  ratio  for  symptomatic  intra cerebral hemorrhagic was 1.75 per 100  
 
mg/dl increase   in   admission   glucose   (95 %   CI 1.11 to  2.78,  p = 0.02).   The  
 
relationship was weaker after  excluding  patients  with  intra cerebral hemorrhage,  
 
suggesting admission   hyperglycemia   may   exert   its   hazard   in   part  through  
 
hemorrhagic events.  However  another  recent  study by Alvarez-Sabin et al found  
 
admission glucose more  than  140  mg/dl (OR 8.4, CI 1.8 to 40.0) to  be   the  sole  
 
independent predictor  of poor functional outcome at three months in patients with  
 
recanalization within  six   hours,  even   after  excluding  the patients symptomatic  
 
intra cerebral  hemorrhage31. The  same  was  not  true for the patients who did not  
 
recanalize, which leads to speculation that might partially preclude the beneficial  
 
effect of r-tPA and early reperfusion. 
 
 
PRIMARY  AND SECONDARY  PREVENTION 
 
 
Atherosclerosis Risk Factors   
 
                  Hypertension is the most significant of the risk  factors;  in  general,  
all hypertensives should be treated. Coronary artery disease is the most common 
cause of death in patients with cerebrovascular disease, treatment of 
hypercholesterolemia  seems  prudent  for   both   the  heart   and    brain. Tobacco  
 
29 
smoking should be discouraged in all patients       
Antiplatelet Agents          
   Platelet antiaggregation agents can prevent atherothrombotic 
events,  including TIA and stroke, by inhibiting the formation of intra-arterial 
platelet aggregates. These can form on diseased arteries, induce thrombus 
formation, and occlude the artery or embolize into the distal circulation. 
 The  antiplatelet agents used most for this purpose  are : 
 
                          Aspirin,  
 
                         Clopidogrel, and  
 
                         The combination of aspirin plus extended-release Dipyridamole 
 
Anticoagulation Therapy 
ATHEROTHROMBOTIC STROKE   
        
                There are few data to support the use of long-term  warfarin  for 
preventing  atherothrombotic stroke, either intra cranially or extra cranially. 
          
EMBOLIC STROKE   
 
 Several recent trials demonstrated that anticoagulation (INR range 2 
to 3) in  patients with chronic non valvular (non rheumatic) atrial fibrillation 
prevents cerebral embolism and is safe.       
      For  primary  prevention  and  for  patients who have  experienced  
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stroke or TIA, anticoagulation with warfarin reduces the  risk  by  about  65%  and  
clearly   outweighs the 1% per year rate of major bleeding complication. 
 Because of the high annual stroke risk in untreated rheumatic heart 
disease,  primary prophylaxis against stroke has not been studied in a double-   
blind fashion. These patients generally receive long-term anticoagulation. 
   Anticoagulation also reduces the risk of embolism in acute 
myocardial infarction. Most clinicians recommend a 3-month course of 
anticoagulation when there is anterior Q-wave infarction, substantial  Left 
ventricular dysfunction ,congestive heart failure, mural thrombosis, or atrial 
fibrillation .Warfarin is recommended long-term if atrial fibrillation persists.     
Thromboembolism is one of the  most  serious  complications  of  prosthetic  heart                            
valve implantation. Anticoagulation has been proven effective for preventing 
strokes in this situation, while antiplatelet therapy alone has not.   
   However, coupled with warfarin anticoagulation, aspirin adds 
substantial benefit. A greater degree of anticoagulation (INR of 3 to  4,  depending  
on valve type) is recommended for prosthetic heart valve patients. 
  
SURGICAL THERAPY  
 
                         Surgery for atherosclerotic occlusive disease is largely limited to 
carotid   endarterectomy  for  plaques  located  at  the  origin of the internal carotid  
artery in the neck  
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     Carotid endarterectomy  is  a  proven effective prophylaxis against  
stroke and TIA.   
 
 Stroke Centers and Rehabilitation      
  
                               Comprehensive stroke units that care for the acute patient     
followed by rehabilitation services have been shown to improve neurological 
outcomes and reduce mortality.       
           Proper rehabilitation of the stroke patient includes early 
physical, occupational, and speech therapy. It  is  directed  toward  educating    the  
patient and family about the patient's neurological deficit, preventing the 
complications of immobility (e.g., pneumonia, deep vein thrombosis and 
pulmonary  embolism , pressure  sores  of   the  skin,   muscle  contractures),   and  
providing encouragement and instruction in  overcoming  the deficit. The  goal  of                            
rehabilitation is to return the patient to home and to maximize recovery by 
providing a safe, progressive regimen suited to the individual patient 
 
 
                                    INTRA CEREBRAL HEMORRHAGE 
                           
                          Intra cerebral hemorrhage accounts for approximately 15%-25% 
of the strokes. The overall mortality for this type subtype of stroke is from 25 % to 
60%   In nearly  70% of patients Hypertension is the commonest cause of bleed.
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               The lipohyalinosis of the small intraparenchymal arteries is the 
leading cause of  hemorrhage. 
.                The micro aneurysms of charcot and  Bouchard is uncertain, but 
they are found at anatomical sites preferentially affected by ICH. 
Hyperglycemia  And  Hemorrhagic  Stroke : 
  
                         Incidence  of   hemorrhagic   stroke   is   higher   in  diabetes either  
 
known diabetes or newly detected diabetes. This is due to the fact that blood  brain  
 
barrier is disrupted by chronically elevated hyperglycemia which is dealt earlier in  
 
the topic ‘thrombolysis of ischemic patients with hyperglycemia’ 
  
The non Hypertensive causes include following : 
 
1. bleeding disorders, anticoagulant and fibrinolytic treatment 
 
2. cerebral amyloid angiopathy 
 
3. granulomatous angitis  of the CNS 
 
4. sympathomimetic agents 
 
5. trauma  
 
6. hemorrhagic infarction 
 
7. vascular malformations 
 
       8.  Intra cranial tumors 
                                                                                                                                                
clinical features: 
     
      symptoms of increased  ICT 
 
      symptoms that are specific for the location of the hematoma 
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       focal neurological deficits 
 
 
 
Imaging 
 
The  CT scan is sensitive to the high density fresh blood in the 
parenchyma while MRI can determine the time duration between the    
hemorrhage and the MRI examination 
 
 common  sites : 
 
     1 . Putamen  - 35 % 
 
     2 . Lobar – 25 % 
 
     3 . Thalamus – 10-15 % 
 
     4 . Caudate nucleus – 5 % 
 
     5 . Pons – 5 % 
 
6. Cerebellum – 5 – 10 % 
 
 
 Treatment  
 
                 Control of hypertension 
         
                 Air way maintenance if the GCS is less than 8 
 
                 Treatment of coagulation abnormalities 
                                                                                                                                               
                 Protamine sulfate is used if the  hemorrhage is due to heparin 
Cryoprecipitate is used if the  hemorrhage is due to heparin   
       Measures for the prevention of further elevation of  ICP   
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           Routine  anticonvulsants not recommended  in  patients  who  do  not 
have seizures at onset due to negligible risk of subsequent epilepsy in them. 
            Patients with lobar  hemorrhage  and  cerebellar  hemorrhage can  be 
managed surgically whereas the deep hemorrhages are managed medically. 
 
 
MORTALITY  IN  STROKE :  
 
 
Early mortality ( first thirty days ) : 
 
Generally death occurs with in first 1 days and is secondary to large infarction  
 
leading to cerebral edema and raised Intra cranial tension. These patients can be  
 
clinically identified by  
 
1. Severe fall in level of consciousness. 
 
2. Gaze paresis. 
 
3. Hemianopia. 
 
4. Dilated pupil on the infracted side. 
 
5. Abnormal type of respiration. 
 
     In such patients CT scan will reveal large hemispherical infarct with edema and  
 
midline shift and  or brain stem infarct. 
 
 
Other causes after 10 days : 
 
1. Aspiration pneumonitis. 
 
2. Bed sores. 
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3. Infections. 
 
4. Pulmonary embolism. 
 
Late mortality : 
 
                     Important causes are IHD and recurrent stroke. 
 
 
 
SUMMARY  OF  EVIDENCE  SUPPORTING   A   DETRIMENTAL  ROLE  
 
FOR ELEVATED GLUCOSE IN STROKE 
 
                     1.  Experimental ischemic damage is worsened by hyperglycemia 
                          
                     2. Experimental ischemic damage is reduced by glucose reduction 
                          
                     3. Early hyperglycemia is associated with clinical infarct progression    
 
                          in brain imaging 
                          
                      4. Early hyperglycemia is associated with hemorrhagic conversion in  
 
                          stroke 
                           
                      5. Early hyperglycemia is associated with poor clinical outcome 
                           
                      6.Early hyperglycemia may reduce the benefits of recanalization  
                          
                      7.  Immediate insulin therapy reported beneficial in acute myocardial  
                                                                                                                                 
                          infarction and surgical critical illness. 
 
 
    CONCLUSION 
 
                                         This recent  evidence  supports  that acutely elevated,  
 
predominantly stress  related hyperglycemia  is  associated  with  poor outcome  
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such as   dependent  state  or  intra   cerebral  hemorrhage.   Through   different  
 
biochemical  mechanisms ,  increased   glucose  in  setting of  cerebro  vascular  
 
insults probably  accelerates the course of ischemic injury, also in the boundary  
 
regions  with  milder  perfusion deficit. Although admission hyperglycemia has  
 
been already  demonstrated  to  be risk factor  for symptomatic hemorrhage and  
 
worsened  outcome  after  thrombotic  therapy,  there  is   perhaps  not   enough  
 
evidence to withhold  thrombolysis  from  hyperglycemic  patients  within   the  
 
three hour time window. How ever restoration of   normoglycemia  as  soon  as  
 
possible should be encouraged ,although conclusive evidence of decreased risk 
 
with this approach is lacking. Especially the non diabetic patients may be a risk  
 
of   further  brain   damage  if  hyperglycemia  prevails . The   recent   evidence  
 
summarized above  urges  corroboration  in  randomized  controlled trial of the  
 
efficacy of immediate sugar control, and determination of where  the  level  of  
 
target  glucose  concentration   of   relatively  different  current   values  in   the  
 
published  guidelines  (EUSI < 10 mmol/l; ASA < 300 mg/dl) 7   should  be set.  
 
In  the  interim,  we  should  fare  well  with  adhering  to  good  general  stroke  
 
management,  including  control  of   blood  glucose , normalization   of    body  
 
temperature, fluid  balance   and homodynamics  or  we may otherwise risk the  
 
favorable outcome even in the patients with early recanalization. 
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                      MATERIALS  AND  METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.MATERIALS  AND  METHODS 
 
 
A total of hundred and nine patients of acute stroke admitted in the  department  
 
of medicine, Government  Stanley  Hospital,  Chennai between August 2005 to  
 
May 2006 were studied. The Patients were selected on the following basis  
 
 
INCLUSION CRITERIA: 
                
           1.  Patients should be above the age of forty 
                
           2.  Patients  should  have been  admitted  within   twenty   four  hours of  
 
                onset of symptoms 
                 
           3. This should be the first cerebro vascular accident for the patient  
                 
           4. Blood sugar recorded with in twenty four hours of the onset of stroke 
 
 
EXCLUSION CRITERIA: 
                
            1.   Patients admitted after twenty four hours of stroke 
                  
            2. Those  patients  who received intravenous  glucose before or during  
 
                study period 
                
            3.  Patients  with  reliable  information  about  diabetes  could  not  be  
 
                obtained 
                
             4. Patients who died before it could be established whether or not they  
 
                had diabetes 
               
             5. Illness presented with stroke like symptoms 
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                  Out  of the  hundred  and nine patients, nine were dropped as follow  
 
up could not be done.  
               
                 Complete  history  was  taken,  clinical  examination  was  done  and  
 
clinical diagnosis for each patient was arrived. 
                
                Blood   pressure   measurement ,   blood    sugar ,  urea ,   creatinine ,  
 
electrolytes,  hemoglobin,  total  count, differential count; urine sugar, albumin,  
 
deposits; electrocardiogram and chest X ray done for all patients 
              
               The severity  of  stroke  for  each  patient  is calculated  based on NIH  
 
stroke scale, NIHSS32 which takes the following clinical findings in to  account  
 
and each criteria awarded  specific points 
 
     1a Level of conscious 
                        
                       Alert              0 
                       
                       Drowsy          1 
                       
                       Stuporous      2 
                       
                       Comatose      3 
 
    1b LOC questions 
                   
                      Answers both correctly       0 
                  
                      Answers one correctly        1 
                  
                      Incorrect                              2 
 
    1c LOC commands 
                  
                     Obeys both correctly           0 
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                   Obeys one correctly            1 
                   
                    Incorrect                             2 
 
    2 Best gaze 
                  
                    Normal                                0 
                  
                    Partial gaze palsy                1 
                  
                    Forced deviation                 2 
 
    3 Visual 
                  
                  No visual loss                       0 
                   
                   Partial hemianopia               1 
                   
                   Complete hemianopia          2 
                  
                   Bilateral hemianopia            3  
 
    4 Facial palsy 
                  
                   Normal symmetric                0 
                   
                   Minor paralysis                     1 
                  
                   Partial paralysis                     2 
                  
                   Complete paralysis                3 
 
    5 Best motor arm/ leg (right/left) 
                 
                   No drift                                 0 
                 
                  Drift                                        1 
                  
                  Some antigravity effect          2 
                  
                  No antigravity effect              3 
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                  No movement                        4 
 
   6 Limb ataxia      
                   
                  Absent                                   0 
                  
                  Present in one limb                1 
                  
                  Present in both limbs             2 
 
   7 Sensory 
                  
                  No sensory loss                      0 
                  
                Mild to moderate sensory loss 1 
                   
                  Total sensory loss                   2 
 
  8 Best language 
                   
                       Normal, no aphasia            0 
                  
                        Mild to moderate aphasia  1 
                   
                        Severe aphasia                   2 
                  
                         Mute, global aphasia         3  
 
 9 Dysarthria 
                   
                         Normal                              0 
                  
                         Mild to moderate              1 
                  
                         Severe                               2 
 
 10 Extinction/ inattention 
                   
                         No abnormality                                                  0 
                  
                         Visual/ tactile/ spatial/ personal inattention       1 
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                         Profound hemi inattention                                  2 
 
The points were added, with a maximum of thirty points. 
  
                  Once  clinical  diagnosis  of  acute  stroke   is  made  venous  blood  
 
sample is  taken, with  in  twenty  four  hours of onset of symptoms, and sent to  
 
laboratory for glucose estimation. 
 
                  In patients with blood sugar more than 6.1 mmol/l(110 mg/dl) 22 and  
 
with out a history of diabetes , Hemoglobin A 1c was performed. (Hemoglobin  
 
A1c is  structurally  similar to hemoglobin A except for the addition of glucose  
 
Group   to  the   terminal   amino  acid  of  the    beta  chain of  the  hemoglobin  
 
Molecule (glycosylation).  Therefore  hemoglobin  A 1c   is  a  function  of  the  
 
exposure of  the  red  blood  cells  to  glucose. Since   the  glucose   linkage   to  
 
hemoglobin is  relatively  stable, Hemoglobin A1c accumulates  through out of  
 
the life  span  of  erythrocyte  and its concentration reflects the integrated blood  
 
glucose   concentration   over   a   period   approximating   to   the  half   life  of  
 
erythrocytes i.e.  six to  eight  weeks. Therefore measurement of hemoglobin A  
 
1c helps  to   monitor  the  overall  degree  of  diabetic  control  achieved).  The  
 
normal  range  of  Hemoglobin  A 1c  is  3.8% to 6.4%33.  Hence   the   patients  
 
can be classified into four groups  
 
     Blood sugar less than 6.1 mmol/l : Non diabetic (euglycemic) 
 
     History of diabetes : Known diabetics 
 
     Blood sugar more than 6.1mmol/l, no history of diabetes, and hemoglobin A1c  
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more than 6.4% : Newly detected diabetics 
 
Blood sugar more than 6.1 mmol/l, no history of diabetes, and hemoglobin A1c  
 
less than 6.4% : Stress hyperglycemics 
 
             Then computerized tomography, CT, of the brain was performed in all  
 
patients to : 
                            Confirm the diagnosis 
                  
                            Detect the type of stroke  
                  
                            Detect the size of lesion (small < 5mm; Medium 5 – 10 mm;  
 
Large > 10 mm or involving more than one vascular territory) 
                  
                            Locate the site of lesion 
                  
                            Identify the presence of cerebral edema or midline shift 
                   
                    The  patients  were  followed  up  for  thirty  days  and  outcome in  
 
the form   of  death ;  poor,  moderate  and  good  improvement  were recorded.  
 
Patients  who  were  unable   to   return   to  any   form  of   work34,   persistent   
 
disability35, need  for residential  placement36,dependent  in  activities  of  daily  
 
living37, and  stable  deficit with no  recovery38 were  classified   as  those  with   
 
poor  outcome. Patient  whose symptoms   improved, who   were   independent   
 
in  attending   day  to  day  activities,  improvement   in   motor   function   and   
 
aphasia  and   no  persistent  disability  were  grouped  as  patients   with  good  
 
outcome. Patients who fared  in  between  these  two  groups  were  grouped  as  
 
those with moderate outcome. 
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                   OBSERVATION  AND  RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         
 
                             5. OBSERVATION  AND  RESULTS 
 
 
 
 
SEX DISTRIBUTION : 
 
 
 
     
                              
      
       AGE WISE DISTRIBUTION : 
 
        
                     
Age Male Female Total % 
 
41 - 50 
 
16 
 
4 
 
20 
 
20 
 
51 - 60 
 
28 
 
10 
 
38 
 
38 
 
61 - 70 
 
9 
 
11 
 
20 
 
20 
 
71 - 80 
 
10 
 
9 
 
19 
 
19 
 
>80 
 
3 
 
0 
 
3 
 
3 
  
66 
 
34 
 
100 
 
100 
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Sex No of cases % 
male 66 66% 
female 34 34% 
 
 
 
 
RISK FACTORS : 
 
 
 
 
     
 
Risk factors Male % Female % Total 
 
hypertension 
 
42 
 
63.64 
 
24 
 
36.36 
 
66 
 
diabetes 
 
17 
 
60.71 
 
11 
 
 
39.29 
  
28 
Hyper 
cholesterolemia 
 
10 
 
71.43 
 
4 
 
 
28.56 
 
 
14 
 Atrial 
fibrillation 
 
0 
 
0 
 
1 
 
100 
 
1 
Coronary 
artery disease 
 
4 
 
66.66 
 
2 
 
33.33 
 
6 
 
smoking 
 
40 
 
100 
 
0 
 
0 
  
40 
 
alcohol 
 
25 
 
96.15 
 
1 
 
3.85 
  
26 
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CLINICAL PRESENTATION : 
 
Clinical presentation 
 
Male % Female % Total 
Right hemiplegia 38 69.1 17 30.9 55 
Left hemiplegia 25 64.1 14 35.9 39 
Faciobrachial 
monoplegia 
2 40 3 60 5 
Cerebellar symptoms 1 100 0 0 1 
Loss of consciousness 31 60.8 20 39.2 51 
Hemianopia 2 66.6 1 33.3 3 
Aphasia 22 57.9 16 42.1 38 
Bladder and Bowel 
involvement 
16 59.3 11 40.7 27 
 
 
 GLYCEMIC STATUS : 
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Glycemic status 
 
Total 
 
    Euglycemia 
 
44 
        Stress  
  Hyperglycemia 
 
28 
        Known 
       Diabetes 
 
 
16 
 Newly diagnosed 
       Diabetes 
 
12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GLYCEMIC  STATUS
12
16
28
44
Newly diagnosed
diabetes
Known diabetes
Stress
hyperglycemia
Euglycemia
 
 
 
 
 
 
 
STROKE   SEVERITY : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 Statistical  Analysis : 
  N Mean 
Std. 
Deviation 
Oneway 
ANOVA 
F_test 
 
Euglycemia 44 9.50 6.760
 
Stress 
hyperglycemia 
28 16.32 7.040
 
Known diabetes 16 17.38 6.561
 
Newly detected 
diabetes 
12 19.42 5.248
 
Total 100 13.86 7.671
F=11.85 
P=0.001 
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                 Glycemic status       NIHSS 
Euglycemia 9.5 
Stress hyperglycemia 16.33 
Known diabetes 17.3 
Newly diagnosed diabetes 19.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19.4
17.3
16.33
9.5
0 5 10 15 20
Newly
diagnosed
diabetes
Known
diabetes
Stress
hyperglycemia
Euglycemia
1
2
3
4
NIHSS
NIHSS
 
 
 
      Ischemic 
        stroke 
   Hemorrhagic 
        stroke 
 
     Glycemic 
        status 
    NO      %      NO       % 
 
 
        Total 
Euglycemia 34 77.27 10 22.73 44 
Stress 
hyperglycemia 
23 82.14 5 17.86 28 
Known  
diabetes 
10 62.5 6 37.5 16 
Newly diagnosed 
Diabetes 
6 50 6 50 12 
 
 
 
SIZE  OF  THE  LESION : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              χ2 = 42.5, p = 0.001. 
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    Glycemic status 
 
Total
 
   Small
 
Medium 
 
  Large 
 
Euglycemia 
 
44 
 
29 
 
8 
 
7 
 
Stress 
Hyperglycemia 
 
28 
 
1 
 
14 
 
13 
 
Known Diabetes 
 
16 
 
2 
 
6 
 
8 
 
Newly Detected 
Diabetes 
 
12 
 
0 
 
6 
 
6 
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CLINICAL   OUTCOME  : 
 
 
 Death   Poor   Moderate    Good  
Glycemic 
Status 
 
Total 
 
NO 
   % NO   % NO   % NO     % 
Euglycemia 44 7 15.91 2 4.54 6 13.64 29 65.91 
Stress 
Hyperglycemia 
28 10 35.71 8 28.57 9 32.14 1 3.54 
Known  
Diabetes 
16 7 43.75 3 18.75 5 31.25 1 6.25 
Newly 
diagnosed 
diabetes 
12 6 50 4 33.33 2 16.67 0 0 
 
     
 
  Statistical  Analysis of Out Come : 
 
 
  outcome Total 
  Good Moderate Poor Death   
group  
Euglycemia 29 6 2 7 44
   
Stress 
hyperglyce
mia 
1 9 8 10 28
   
Known 
diabetes 
1 5 3 7 16
   
Newly 
detected  
diabetes 
0 2 4 6 12
 
Total 31 22 17 30 100
 
χ2=48.3, P=0.001  
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OUTCOME  IN  STROKE  SUBTYPES : 
 
 
 
 
Hemorrhage:    χ2=12.75, P=0.17 (Not significant)  
 
Infarct          :    χ2=50.6, P=0.001 (Significant)  
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outcome 
 GLYCEMIC STATUS 
  Good Moderate Poor Death Total
group Euglycemia 3 3 0 4 10
 
Stress hyperglycemia 0 1 1 3 5
 
Known diabetes 0 3 2 1 6
 
Newly detected diabetes 0 2 3 1 6
H 
E 
M 
O 
R 
R 
H 
A 
G 
E  
Total 3 9 6 9 27
 
Euglycemia 26 3 2 3 34
 
Stress hyperglycemia 1 8 7 7 23
 
Known diabetes 1 2 1 6 10
group 
 
Newly detected diabetes 0 0 1 5 6
 
I 
N 
F 
A 
R 
C 
T  
 
Total 28 13 11 21 73
OUTCOME   OF  STROKE   IN  NON DIABETES PATIENTS : 
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Ischemic   stroke 
 
Hemorrhagic   stroke 
 
Euglycemia  Stress 
Hyperglyc- 
        emia 
Euglycemia Stress 
Hyperglyce- 
             mia 
 
Total 
 
34 
 
23 
 
10 
 
5 
 
NIHSS 
 
7.62 
 
15.56 
 
14.4 
 
19.8 
 
    No   
 
3 
 
7 
 
 
4 
 
3 
    
Death 
    
  %  
       
 
8.82 
 
30.43 
 
40 
 
60 
    
 No 
             
 
2 
 
7 
 
 
0 
 
1 
    
Poor 
     
% 
         
 
5.58 
 
30.43 
 
0 
 
20 
  
  No 
      
 
3 
 
8 
 
3 
 
1 
 
Moderate 
   
  % 
         
 
8.82 
 
34.78 
 
30 
 
20 
  
  No 
       
 
26 
 
1 
 
3 
 
0 
 
Good 
    
 % 
         
 
76.47 
 
4.35 
 
30 
 
0 
 
Average  blood  
Glucose level 
 
91.68 
 
144.43 
 
102.12 
 
240.6 
       CORRELATION  OF  SUGAR  LEVEL  AND  OUTCOME  IN  BOTH   
 
       SUBTYPES  OF  STROKE: 
 
 
 
  A  <110 mg/dl ; B = 110-125 mg/dl ; C = 126-199 mg/dl ; D > 199 mg/dl 
     
     Hemorrhage : χ2=26.1, P=0.001 (Significant)  
      
     Infarction     : χ2=81.9, P=0.001 (Significant) 
 
     Positive correlation, r = 0.71, p = 0.001. 
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Outcome 
 Good Moderate Poor Death Total 
SUGAR  
A 3 3 0 4 10
 
B 
 
 
0 1 1 0 2
 
C 0 5 0 0 5
 
D 0 0 5 5 10
H 
E 
M 
O 
R 
R 
H 
A 
G 
E 
 
Total 3 9 6 9 27
 
A 26 3 2 3 34
 
B 1 8 7 0 16
 
C 1 2 0 3 6
SUGAR 
 
D 0 0 2 15 17
 
I 
N 
F 
A 
R 
C 
T 
 
 
Total 28 13 11 21 73
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6.DISCUSSION 
 
 
AGE,  SEX  AND  RISK  FACTORS: 
                      
                          In our study of hundred patients majority of them  belonged  to  
 
male sex  showing  a  male  preponderance which  is  commonly  seen  in  most  
 
studies. Majority of the patients, thirty eight, were between the age group of 51  
 
to 60. Among  the  hundred  patients  66  had hypertension, 28 had diabetes, 14  
 
had hypercholesterolemia, 6 had previous history of myocardial infarction, and  
 
one  lady  had  atrial  fibrillation.  More   than  half   of  the  male patients were  
 
smokers and  one  third had  history  of  alcohol intake. Sixty patients had right  
 
sided weakness and forty patients had left sided weakness. 
 
 
GLYCEMIC  STATUS : 
 
                       Among the hundred patients  in  our study group, 56 patients had  
 
elevated admission day  blood  glucose  level and 44 patients had normal blood  
 
glucose values. Diabetes  was  noticed  in 28 patients and stress hyperglycemia  
 
in   another   28   patients .  In  ischemic  stroke   group   stress   hyperglycemia  
 
amounted to one third of the patients and one fifth in hemorrhagic group. 
 
 
SEVERITY  OF  STROKE : 
  
                      Severity of  stroke  was assessed with NIH Stroke scaling system.  
 
Admission day  hyperglycemic  patients  had  a higher score when compared to  
 
Euglycemic  patients   (  17.27 vs.  9.5 respectively) ,  which   was   statistically  
53 
      significant with  p = 0.001. Among  the  admission day hyperglycemic patients  
 
newly detected diabetes had the highest mean NIHSS. Hence an elevated blood  
 
sugar at the time of stroke resulted in severe stroke.  
 
 
SIZE  OF  STROKE: 
 
                      The size of   the  lesion  were  analyzed  with the help of CT scan  
 
brain. Most of the euglycemic patients had small sized infarcts and hemorrhage  
 
whereas majority  of  the admission day hyperglycemic patients had large sized  
 
lesion  with edema and midline shift. These data’s were statistically significant  
 
with  p = 0.001. Hyperglycemia by  virtue  of  increased anaerobic metabolism,  
 
increased  brain  lactate, impaired   mitochondrial   function,  vascular  disease,  
 
increased  free  radical  production,  increased   expression  of c-fos  and  cox-2  
 
causes severe  brain  injury and large sized infarcts. Hyperglycemia can disrupt  
 
the  blood  brain   barrier   resulting   in   large   hemorrhage   and  hemorrhagic  
 
transformation of infarcts. 
 
 
TYPE  OF  STROKE : 
 
                       Among  the  euglycemic  group  three  fourth  of the patients had  
 
ischemic stroke  and  one  fourth had hemorrhagic stroke. Among patients with  
 
admission day hyperglycemia one third of the patients had hemorrhagic stroke.  
 
In the  newly  detected  diabetes  patients  half of them had hemorrhagic stroke.  
 
Our  study  shows  an   increasing   incidence  of  hemorrhagic  stroke   among  
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diabetes patients. 
 
      OUTCOME OF  STROKE : 
 
                         In  this  study  of   hundred   acute   stroke   patients,   euglycemic  
 
patients had a  better outcome when compared to admission day hyperglycemic  
 
patients. 
 
                   Euglycemic  patients  had  a   better  recovery  after  acute  stroke.  
 
Sixty five  percent  of  euglycemic  patients had a good functional recovery. On  
 
the contrary  only  three  percent  of admission day hyperglycemic patients had  
 
good functional recovery at the end of thirty day follow up. 
 
                   Early inpatient mortality was high in admission day hyperglycemic  
 
patients. Forty percent  of  the  admission day hyperglycemic patients died with  
 
in the first  thirty days. In  the  euglycemic  patients  the  early case fatality rate  
 
was only  fifteen percent. Hence  there  was a two and a half fold increased risk  
 
of early mortality in admission  day  hyperglycemic patients when compared to  
 
euglycemics. Poor outcome was noticed in  twenty seven percent of  admission  
 
day hyperglycemic patients and in four percent of euglycemic patients. 
 
                      This    study    of   hundred   acute    stroke   patients   shows  that  
 
admission day  elevated  blood  glucose  level  was associated with a high early  
 
mortality rate and an increased risk of poor functional recovery. 
 
                     These  data’s   were   statistically  significant  with  χ2=48.3   and  
 
p=0.001. 
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                        In the ischemic  stroke  group early mortality rate was 8.82 % in  
 
euglycemic patients and 46.15 % in hyperglycemic patients. Poor outcome was  
 
noticed   in   5.88 %  in  euglycemics  and  23.3 %  in   hyperglycemics.  Hence  
 
hyperglycemia was  associated  with  an increased early mortality rate and poor  
 
functional outcome   in   ischemic   stroke   group  which  was  also statistically  
 
significant with : χ2=50.6   P=0.001. 
 
                       In the hemorrhagic patients the early mortality in hyperglycemic  
 
patients was  29.4 %  and  40 %  in  euglycemic patients which was statistically  
 
insignificant with  χ2=12.75  P=0.17. 
 
                      In the non diabetes ischemic stroke patients stress hyperglycemia  
 
had worst  outcome  when  compared to euglycemic group. The early mortality  
 
rate was  30.43 %  in stress  hyperglycemics and 8.82 % in euglycemics. Hence  
 
this study  shows  a  three   and   a   half   fold   increased   risk  of mortality  in  
 
non diabetes   stress  hyperglycemic  patient  when  compared  to  non  diabetic  
 
euglycemic  patients  which   was  also  statistically  significant  with  p=0.001.  
 
However similar significance was not noticed in the hemorrhagic group. 
 
                         Our study clearly shows a positive correlation ( r = 0.71, p =  
 
0.01 ) between admission day sugar value and the outcome of stroke. Higher  
 
admission day elevated blood glucose level  has increased mortality and high  
 
risk of poor functional recovery. 
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     COMPARISION  WITH  OTHER  STUDIES : 
 
                        According    to    Perttu   J.  Lindsberg     and    Risto  o  Roine39  
 
hyperglycemia was  noted  in  two  third ( 66% ) of all ischemic stroke patients.  
 
In our study  hyperglycemia  was  noticed  in  56% of patients in general and in  
 
55% of patients  with ischemic stroke. In their study known diabetes and newly  
 
diagnosed  diabetes  contributed  one  third  of  cases  ( 33% ). In  our study the  
 
same group contributed to 28%. 
 
                      A  study  published  in  European  journal  of  Neurology,  200240  
 
concluded that elevated   glucose  level  after  acute  stroke  is  associated  with   
 
higher  stroke severity  than  those  with  normal  level. The mean NIHSS  was  
 
9.5 in euglycemics and 17.27 in hyperglycemic patients in our study. 
 
                         In the journal of clinical endocrinology and metabolism, 200241  
 
a  study confirmed   that  patients with  newly detected   hyperglycemia  had  a  
 
significant higher  early mortality and a lower functional outcome than patients  
 
with a history of diabetes or normoglycemia. Our study in hundred acute stroke  
 
patients had the same results. 
 
                         Sarah E capes  et  al22  analyzed  thirty two similar  studies  and  
 
concluded that  hyperglycemic  patients had threefold increased early mortality  
 
than euglycemic  patients. After ischemic stroke admission hyperglycemia was  
 
associated with three fold increased  30  day mortality than euglcemics22. After  
 
hemorrhagic stroke, admission  hyperglycemia  was  not associated with higher  
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mortality   in   either   diabetic   or   non  diabetic  patients22. In  our  study,    in    
 
ischemic patients, who had elevated admission day  glucose  level  experienced 
 
 a  three   and   a   half    fold   increased   early   mortality   than   euglycemics.  
 
Hemorrhagic   patients   with   admission   hyperglycemia    did not    show   a  
 
statistically  significant early  mortality  when compared  to   their   euglycemic 
 
counter part. Similar results were noticed in non diabetic patients. Non diabetic  
 
stress hyperglycemic patients with ischemic stroke  had  three  and  a  half  fold  
 
increased early mortality when compared to euglycemics. In the diabetic group  
 
since the sugar value before the onset of stroke  was not  known, the  effect  of  
 
stress in diabetic group could not be studied. 
                        
                       The study clearly shows  an  increased  early  mortality  rate  and  
 
poor functional recovery in patients with diabetes   and   stress   hyperglycemia  
 
when compared to euglycemics. Hence there is an urgent need  to  confirm  the  
 
improvement in these patients by  normalizing  blood  sugar. Several  trails  are  
 
now under   way   to   improve   the   out  come of  Stroke  by  normalizing  the   
 
blood  glucose  with   human   recombinant  insulin. Stephan M. Vinychuk et42 al  
 
showed  that administration   of   insulin   to  patients   with  hyperglycemia  improves  
 
functional    recovery   and   vital   activity  of   mild   to  moderate   ischemic   stroke   
 
patients. However ,  other   clinical   benefits   of  the   insulin   therapy  remain  to  be  
 
determined.  
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                                           CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.CONCLUSION 
 
 
 
 
                   There is a linear  correlation between admission day hyperglycemia  
 
and stroke  in its severity, size and outcome . The combined diabetes and stress  
 
hyperglycemics  are  found   to   have   larger  sized  severe  stroke   and   poor  
 
functional   outcome   in  the   form  of  increased   mortality. There  is  a  good  
 
correlation between  admission  day glucose level and the outcome in ischemic  
 
stroke. Admission  day  elevated glucose  level  was  a  significant predictor of  
 
mortality and  poor  functional  outcome after  acute stroke. Hence,  restoration   
 
of    normoglycemia    as    soon  as   possible   should  be  encouraged   though  
 
conclusive evidences  are  lacking. In  the  interim,  we  should  fare  well  with     
 
adhering   to   good   general   stroke   management,  normalization    of    body  
 
temperature, fluid  balance   and hemodynamics  or  we  may otherwise risk the  
 
favorable   outcome   even  in  the  patients  with  normoglycemia. 
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                                                  9.PROFORMA 
 
 
NAME OF THE PATIENT : 
 
AGE :                                 SEX :                               IP NO : 
 
ADDRESS :                                                OCCUPATION : 
 
 
 
CHIEF COMPLAINTS : 
 
 
 
HISTORY OF PRESENTING COMPLAINTS : 
 
 
 
PAST HISTORY : 
 
HT / DM / TIA / PT / BA / COPD / CRF / CAHD / DCMP / RHD / AS / MVP  
 
/ HEPATIC DISEASE / SEIZURES / PSYCHIATRIC DISORDERS   
 
 
PERSONAL HISTORY :   SMOKING, ALCOHOLISM, DIET 
 
 
GENERAL EXAMINATION : 
 
 
VITALS :  BP, PULSE RATE, RESPIRATORY RATE AND PATTERN 
 
 
 
CLINICAL EXAMINATION : 
 
                            CENTRAL NERVOUS SYSTEM : 
 
                             CARDIOVASCULAR  SYSTEM : 
 
                                                               
                              RESPIRATORY SYSTEM : 
 
                              ABDOMEN  EXAMINATION : 
 
                               SPINE  AND CRANIUM : 
 
CLINICAL DIAGNOSIS : 
 
 
 
INVESTIGATIONS : 
 
Blood sugar , urea , Serum creatinine 
 
Serum electrolytes : sodium, Potassium 
 
Blood hemoglobin , TC , DC, ESR 
 
Urine albumin , sugar , deposits 
 
Total cholesterol 
 
Electrocardiogram 
 
Chest X ray 
 
CT scan brain 
 
Glycosylated Hemoglobin when required 
 
 
 
 
FINAL   DIAGNOSIS  : 
 
 
 
PROGNOSIS (30 DAY FOLLOW UP) :     Good / Moderate / Poor / Death 
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